Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
While lobbying shapes medical policy across the board, it has had a profound impact on the opioid epidemic as deaths quadrupled between 1999 and 2015.
Simplified Text
Lobbying has profoundly impacted the opioid epidemic as deaths quadrupled 1999-2015
Confidence Score
0.900
Claim Maker
Chris McGreal
Context Type
News Article
Context Details
{
    "topic": "Opioid Crisis",
    "influence": "Lobbying",
    "statistic": "Deaths quadrupled",
    "timeframe": "1999-2015"
}
UUID
9fdb30ba-bab4-4d9b-a845-3ad6f402eae4
Vector Index
✗ No vector
Created
September 12, 2025 at 12:40 AM (16 hours ago)
Last Updated
September 12, 2025 at 12:40 AM (16 hours ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis
https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis

Pharmaceutical industry lobbying and campaign contributions heavily influence US politics, hindering efforts to curb the opioid crisis. This influence is seen in legislation, impacting drug pricing and the DEA's ability to regulate opioid distribution.

Opioid Crisis
Pharmaceutical Industry
Lobbying
US Politics
Campaign Finance
Healthcare Policy

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP